Jump to top menu Jump to main menu Jump to content
Profile picture of Alan Abdulla
Researcher

A. (Alan) Abdulla

PhD-student

  • Department
  • Hospital Pharmacy and Intensive Care

About

Field(s) of expertise

  • PK/PD antibiotics
  • Critically ill patients
  • Therapeutic drug monitoring (TDM)

Education and career

  • Hospital Pharmacist | 1/2018 - present
    Erasmus University Medical Center, Rotterdam, the Netherlands.
  • PhD candidate | 1/2018 - present
    Erasmus University Medical Center, Rotterdam, the Netherlands. Thesis subject: Dose individualization of Beta-lactams and Ciprofloxacin in ICU patients.
  • Resident Hospital Pharmacy | 12/2013 - 12/2017
    Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Pharmacist | 9/2012 - 11/2013
    Martini Hospital, Groningen, the Netherlands.

Publications

A complete overview of publications can be found on Pubmed.

Teaching activities

  • Supervision of various thesis projects of MSc. Pharmacy and Medical students.
  • Different educational activities for the following groups: residents, nurses, medical students, pharmacy technicians, clinical pharmacists.

Scholarships, grants, and awards

GRANTS

  • 2020 – present: An exploratory PK/PD study of cefotaxime, ceftazidime, ceftriaxone, cefuroxime, flucloxacillin and meropenem in PICU patients: is there a need for more precision dosing? Funding: Erasmus University Medical Center MRace PhD Grant (€150K), co-applicant.
  • 2019 – 2023: Dose individualization of Beta-lactam antibiotics in ICU patients: to TDM or not to TDM and the effects on patient outcome. Funding: The Netherlands Organisation for Health Research and Development ZonMw (€500K), co-writer.
  • 2018 - 2022 Expansion of DOLPHIN trail with additional research centers. Funding: Stichting de Merel (€50K), co-applicant.
  • 2018 - 2022 PK/PD of Beta-lactam and Fluoroquinolone antibiotics in critically ill patients. Funding: Erasmus University Medical Center MRace PhD Grant (€150K), co-applicant.

    AWARDS AND HONOURS

  • 2019 Dutch Platform for Pharmaceutical Research - Best publication in 2018, Opwijrda ward.
  • 2018 Residents association (AAV Erasmus MC) - Best Abstract Award.
  • 2017 Dutch Association for Intensive Care (NVIC) - Best Abstract oral presentation Award.